| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8311050 | Clinica Chimica Acta | 2015 | 9 Pages |
Abstract
Type II gene expression can be detected using FBT11-II. This specific recognition could improve the clinical usefulness of assays aimed at either managing aggressive tumors or screening for Down syndrome.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
L. Aldaz-Carroll, S. Richon, V. Dangles-Marie, M. Cocquebert, T. Fournier, F. Troalen, D. Stevens, B. Guery, A.-M. Hersant, J. Guibourdenche, A. Nordor, A. Pecking, D. Bellet,